Cite
Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.
MLA
Chen, Ke, et al. “Rab31 Promotes Metastasis and Cisplatin Resistance in Stomach Adenocarcinoma through Twist1-Mediated EMT.” Cell Death & Disease, vol. 14, no. 2, Feb. 2023, p. 115. EBSCOhost, https://doi.org/10.1038/s41419-023-05596-4.
APA
Chen, K., Xu, J., Tong, Y.-L., Yan, J.-F., Pan, Y., Wang, W.-J., Zheng, L., Zheng, X.-X., Hu, C., Hu, X., Shen, X., & Chen, W. (2023). Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT. Cell Death & Disease, 14(2), 115. https://doi.org/10.1038/s41419-023-05596-4
Chicago
Chen, Ke, Ji Xu, Yu-Ling Tong, Jia-Fei Yan, Yu Pan, Wei-Jia Wang, Li Zheng, et al. 2023. “Rab31 Promotes Metastasis and Cisplatin Resistance in Stomach Adenocarcinoma through Twist1-Mediated EMT.” Cell Death & Disease 14 (2): 115. doi:10.1038/s41419-023-05596-4.